EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR genome editing using a combined positive and negative selection system

Ishrya Sharma, Kerisa Hall, Shannon Moonah iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0321881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ishrya Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Florida, GainesvilleFlorida, United States of America. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, Selection, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, Hartwell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system is a powerful genome editing tool that has revolutionized research. Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation in humans. Only a subset of these SNPs has been shown to be linked to genetic diseases, while the biological relevance of the majority remains unclear. Investigating these variants of unknown significance could provide valuable insights into their roles in biological processes, disease susceptibility, and treatment responses. While CRISPR/Cas has emerged as a transformative technology, its ability to make single nucleotide substitutions remains a significant limitation. Other techniques in single nucleotide editing, such as base editing and prime editing, offer promising possibilities to complement CRISPR/Cas systems, though they also have their own limitations. Hence, alternative approaches are necessary to overcome the limitations of CRISPR. Here, to improve the feasibility of generating single base edits in the genome, we provide a protocol that introduces a multiple expression and dual selection (MEDS) system, which, alongside CRISPR, utilizes the opposing roles of cytosine deaminase/uracil phosphoribosyltransferase (CD/UPRT) for negative selection and neomycin phosphotransferase II (NPT II) for positive selection. As a proof of concept and to demonstrate feasibility of the method, we used MEDS, along with traditional CRISPR-Cas9, to generate sickle hemoglobin by introducing a point mutation (A → T) in the sixth codon of the hemoglobin beta gene.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsSelection, GeneticHumansPolymorphism, Single Nucleotidebeta-Globins

Substanzen

beta-Globins

Autor:innen und Institutionen

  • Department of Medicine, University of Florida, GainesvilleFlorida, United States of America.
  • Department of Molecular Genetics and Microbiology, University of Florida, GainesvilleFlorida, United States of America.

ORCID-Profile: Shannon Moonah

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • Hartwell Foundation

Zitieren

APA

Sharma, I., Hall, K., & Moonah, S. (2025). CRISPR genome editing using a combined positive and negative selection system. PLOS One. https://doi.org/10.1371/journal.pone.0321881

Vancouver

Sharma I, Hall K, Moonah S. CRISPR genome editing using a combined positive and negative selection system. PLOS One. 2025. doi:10.1371/journal.pone.0321881

BibTeX
@article{Sharma2025,
  author = {Sharma, Ishrya and Hall, Kerisa and Moonah, Shannon},
  title = {CRISPR genome editing using a combined positive and negative selection system},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321881}
}
Kostenlos starten →